Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (‘Lutate’) therapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2197-7364

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (‘Lutate’) therapy ; volume:5 ; number:1 ; day:20 ; month:12 ; year:2018 ; pages:1-9 ; date:12.2018
EJNMMI Physics ; 5, Heft 1 (20.12.2018), 1-9, 12.2018

Creator: Willowson, Kathy P.
Eslick, Enid
Ryu, Hyunju
Poon, Aurora
Bernard, Elizabeth J.
Bailey, Dale L.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40658-018-0232-9

URN: urn:nbn:de:101:1-2019011314381843126288

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Willowson, Kathy P.
Eslick, Enid
Ryu, Hyunju
Poon, Aurora
Bernard, Elizabeth J.
Bailey, Dale L.
SpringerLink (Online service)

Other Objects (12)

Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy

Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry

Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates

Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

90Y/177Lu-DOTATATE therapy: survival of the fittest?

Tissue dose estimation after extravasation of 177Lu-DOTATATE

Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy

Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients

A novel planar image-based method for bone marrow dosimetry in 177Lu-DOTATATE treatment correlates with haematological toxicity

Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas

p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts

Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy

Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy

Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry

Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates

Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

90Y/177Lu-DOTATATE therapy: survival of the fittest?

Tissue dose estimation after extravasation of 177Lu-DOTATATE

Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy

Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients

A novel planar image-based method for bone marrow dosimetry in 177Lu-DOTATATE treatment correlates with haematological toxicity

Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas

p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts

Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy

Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy

Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry

Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates

Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

90Y/177Lu-DOTATATE therapy: survival of the fittest?

Tissue dose estimation after extravasation of 177Lu-DOTATATE

Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy

Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients

A novel planar image-based method for bone marrow dosimetry in 177Lu-DOTATATE treatment correlates with haematological toxicity

Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas

p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts

Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (‘Lutate’) therapy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy

Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry

Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates

Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

90Y/177Lu-DOTATATE therapy: survival of the fittest?

Tissue dose estimation after extravasation of 177Lu-DOTATATE

Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy

Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients

A novel planar image-based method for bone marrow dosimetry in 177Lu-DOTATATE treatment correlates with haematological toxicity

Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas

p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts

Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy

Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy

Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry

Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates

Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

90Y/177Lu-DOTATATE therapy: survival of the fittest?

Tissue dose estimation after extravasation of 177Lu-DOTATATE

Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy

Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients

A novel planar image-based method for bone marrow dosimetry in 177Lu-DOTATATE treatment correlates with haematological toxicity

Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas

p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts

Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy

Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy

Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry

Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates

Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

90Y/177Lu-DOTATATE therapy: survival of the fittest?

Tissue dose estimation after extravasation of 177Lu-DOTATATE

Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy

Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients

A novel planar image-based method for bone marrow dosimetry in 177Lu-DOTATATE treatment correlates with haematological toxicity

Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas

p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts

Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy

Related objects

Reset password